Juan Jesús
Gómez-Reino Carnota
VU University Medical Center
Ámsterdam, HolandaPublicacións en colaboración con investigadores/as de VU University Medical Center (8)
2019
-
Treatment response and drug retention rates in 24 195 biologic-naïve patients with axial spondyloarthritis initiating TNFi treatment: routine care data from 12 registries in the EuroSpA collaboration
Annals of the Rheumatic Diseases, Vol. 78, Núm. 11, pp. 1536-1544
2017
-
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update
Annals of the Rheumatic Diseases, Vol. 76, Núm. 6, pp. 960-977
2013
-
Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions
Annals of the Rheumatic Diseases, Vol. 72, Núm. 4, pp. 482-492
2011
-
American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials
Annals of the Rheumatic Diseases, Vol. 70, Núm. 3, pp. 404-413
-
American college of rheumatology/European league against rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials
Arthritis and Rheumatism, Vol. 63, Núm. 3, pp. 573-586
-
Treating rheumatoid arthritis to target: Multinational recommendations assessment questionnaire
Annals of the Rheumatic Diseases, Vol. 70, Núm. 11, pp. 1999-2002
2008
-
Methods of deriving EULAR/ACR recommendations on reporting disease activity in clinical trials of patients withd-heumatoid arthritis
Annals of the Rheumatic Diseases, Vol. 67, Núm. 10, pp. 1365-1373
-
Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations
Arthritis Care and Research, Vol. 59, Núm. 10, pp. 1371-1377